United States newsroom

NORTHBROOK, Ill., June 9, 2015 /PRNewswire/ -- Astellas today announced that Tarsis Lopez has been appointed to the role of associate director, external and digital communications, as part of the...

NORTHBROOK, Ill., (June 4, 2015) — The Astellas USA Foundation today announced joining the American Red Cross Disaster Responder Program, which gathers donations in advance of major disasters to...

NORTHBROOK, Ill. and ASPEN, Colo., June 4, 2015 /PRNewswire/ -- The Chris Klug Foundation (CKF) is pleased to announce the winners of the second annual Bounce Back Award, presented by Astellas....

TOKYO and NORTHBROOK, Ill., June 1, 2015 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503) announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single...

Data Presented in Plenary Session at AUA 2015 TOKYO and NEW ORLEANS, May 17, 2015 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) announced today that results from its Phase 3b BESIDE clinical...

NORTHBROOK, Ill., May 14, 2015 /PRNewswire/ -- Astellas today announced several abstracts across multiple cancers that will be presented at the 2015 American Society of Clinical Oncology (ASCO)...

NORTHBROOK, Ill., May 13, 2015 /PRNewswire/ -- This year, Astellas commemorates its 10th anniversary by saluting a decade of milestones in patient health, volunteerism and scientific...

CHICAGO (Tuesday, May 12, 2015) – USA Rugby CEO Nigel Melville announced today that the USA Rugby Eagles will make their return to Soldier Field against the Australian Wallabies in a Saturday,...

NORTHBROOK, Ill., May 5, 2015 /PRNewswire/ -- Astellas announced that two abstracts detailing clinical data from studies of enzalutamide and one abstract detailing clinical data from a study of...

NORTHBROOK, Ill., April 27, 2015 /PRNewswire/ -- Astellas announced today that CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, is now available in the United States for the...

Isolation and lack of one-on-one peer connection is the largest challenge facing millennial cancer patients and caregivers 15-39 years old NEW YORK and NORTHBROOK, Ill. (April 27, 2015) – The...

NORTHBROOK, Ill., April 23, 2015 /PRNewswire/ -- Astellas announced today that seven abstracts will be presented on CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, at the 25th...

TOKYO, April 6, 2015 /PRNewswire/ -- Astellas ("Astellas,") (Tokyo: 4503) today announced that Dr. Shontelle Dodson has been named vice president, Medical Excellence, Medical Affairs. Dodson will...

Nominations now being accepted for the award, which will be presented in December at a special event in Aspen, Colorado NORTHBROOK, Ill. and ASPEN, Colo., April 1, 2015 /PRNewswire/ -- Astellas...

Northbrook, Ill. March 26, 2015 – The Astellas USA Foundation today reaffirmed its commitment to inspiring the next generation of scientists by awarding grants to the Museum of Science and...

Northbrook, IL, March 25, 2015 –Astellas (www.astellas.us) has become a national corporate partner of The Trevor Project (www.thetrevorproject.org) to help advance the shared mission of ending...

NORTHBROOK, Ill., March 25, 2015 – Astellas, a leading pharmaceutical company based in Northbrook, Ill., has been named one of America’s Best Employers in the biotechnology industry by Forbes...

NORTHBROOK, Ill. and SAN FRANCISCO, March 16, 2015 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc. (Nasdaq: MDVN)...

NORTHBROOK, Ill., March 6, 2015 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for the use of CRESEMBA®...

Funding will support measles vaccination campaigns in Latin America Washington, D.C. March 5, 2015 – The United Nations Foundation’s Shot@Life Campaign, which helps expand access to...

Astellas is Exclusive Health Sponsor of the 'Ticket2Health' Initiative Promoting a Game Plan for Better Health and Wellness NORTHBROOK, Ill., Feb. 20, 2015 /PRNewswire/ -- Astellas Pharma US,...

NORTHBROOK, Ill., Feb. 19, 2015 /PRNewswire/ -- Astellas announces organizational and personnel changes in the Americas, highlighting the Company's focus on international markets, while also...

NORTHBROOK, Ill., Feb. 13, 2015 /PRNewswire/ -- Astellas Pharma Inc. (hereafter called Astellas or "the Company") President and CEO, Yoshihiko Hatanaka, announces the newest element of its...

NORTHBROOK, Ill., Jan. 22, 2015 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration's (FDA) Anti-infective Drugs Advisory Committee voted unanimously to recommend...

NORTHBROOK, Ill., Dec. 18, 2014 /PRNewswire/ -- Astellas US LLC today announced that the Company's global President and CEO Yoshihiko Hatanaka will present at the 33rd Annual J.P. Morgan...

NORTHBROOK, Ill., Nov. 3, 2014 /PRNewswire/ -- Astellas announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to isavuconazole for the treatment of...

SAN FRANCISCO, CA and NORTHBROOK, IL – October 30, 2014 – Medivation Inc. (NASDAQ: MDVN) and Astellas today announced plans to initiate a global Phase 3 clinical trial that will evaluate the...

Company is Exclusive Healthcare Sponsor of USA Eagles vs. New Zealand All Blacks Rugby Match at Soldier Field on Nov. 1 NORTHBROOK, Ill., Oct. 14, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., in...

NORTHBROOK, Ill., Oct. 8, 2014 /PRNewswire/ -- Astellas reported today that isavuconazole demonstrated successful outcomes in the treatment of mucormycosis according to data from the phase 3...

NORTHBROOK, Ill., Oct. 2, 2014 /PRNewswire/ -- Astellas, a pharmaceutical company based in Northbrook, Ill., launched a new benefits program today to provide support for its almost 3,000 US-based...

NORTHBROOK, Ill., Oct. 1, 2014 /PRNewswire/ -- Astellas has appointed Brian McLellan as the president of Astellas Pharma Technologies in the Americas region. In this role, Brian will be...

NORTHBROOK, Ill., Sept. 16, 2014 /PRNewswire/ -- Astellas announced today it has appointed Christy Noland as a new director of Business Communications & Advocacy, Urology in the Americas. Noland...

WHAT: More than 400 Astellas employees will descend on Dunning Read Conservation Area in Chicago in celebration of Astellas 5th annual Changing Tomorrow Day. The volunteers will build a...

NORTHBROOK, Ill., Sept. 6, 2014 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for isavuconazole...

NORTHBROOK, Ill., Sept. 5, 2014 /PRNewswire/ -- Astellas today announces the appointment of Andrew Lewis as head of communications for the company's Global Medical & Development (GMD)...

NORTHBROOK, Ill., Sept. 5, 2014 /PRNewswire/ -- Astellas announces today the data that will be presented on the anti-fungal isavuconazole at the 4th Interscience Conference on Antimicrobial Agents...

NORTHBROOK, Ill., Sept. 2, 2014 /PRNewswire/ -- Astellas has appointed James Kellerman as the vice president of intellectual property (IP) in the Americas. Kellerman will report directly to Linda...

NORTHBROOK, Ill., July 31, 2014 /PRNewswire/ -- Astellas has appointed Moyra Knight as the head of corporate and employee communications in the Americas region. Knight will report directly to Jeff...

If isavuconazole is approved for invasive candidiasis, QIDP status provides a five-year extension of market exclusivity. NORTHBROOK, Ill., July 16, 2014 /PRNewswire/ -- Astellas today announced...

NORTHBROOK, Ill., July 9, 2014 /PRNewswire/ -- Astellas today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for...

NORTHBROOK, Ill., June 26, 2014 /PRNewswire/ -- Astellas announces the appointment of Marty Golden, J.D. as vice president, Government Affairs, which is effective on July 1, 2014. In this role,...

NORTHBROOK, Ill., June 26, 2014 /PRNewswire/ -- Astellas has named Tatjana Dragovic, J.D., vice president and regional compliance officer for its Americas region. In this role, she will oversee...

- Uhlendorf is leaving his current position as Vice President, Communications and Public Affairs at PhRMA - NORTHBROOK, Ill., June 24, 2014 /PRNewswire/ -- Astellas announces the appointment of...

Special Patient-Focused Event Kicks Off Astellas' Fifth Annual Changing Tomorrow Day Initiative KISSIMMEE, Fla., June 11, 2014 /PRNewswire/ -- About 1,400 Astellas Pharma employees will be...

-Study appears in June 1 online edition- NORTHBROOK, Ill. and SAN FRANCISCO, JUNE 1, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo:...

NORTHBROOK, Ill., May 14, 2014 /PRNewswire/ -- Astellas reported today that the efficacy and safety data of the isavuconazole invasive aspergillosis study (SECURE) were presented at the European...

Eight abstracts will highlight enzalutamide studies in prostate and breast cancers NORTHBROOK, Ill. and SAN FRANCISCO, May 14, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of...

NORTHBROOK, Ill., May 2, 2014 /PRNewswire/ -- Astellas announces the promotion of Bernhardt Zeiher, M.D. ("Bernie") to the position of executive vice president, Global Development and the...

- Bloss to serve on Astellas US Management Committee - NORTHBROOK, Ill., April 16, 2014 /PRNewswire/ -- Astellas US LLC, a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced...

NORTHBROOK, Ill., April 16, 2014 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that it has reached an...